Dilution of Per-Share Equity Value Through a Capital Increase
First written in FY2023. 2 of 3 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2017: 17 of 34 companies on the "Worse" side.
8 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「If we raise funds in the market, including through capital increases, in response to funding needs, the resulting increase in the total number of shares outstanding may dilute per-share value and reduce the value of our shares,」
The company reiterates the risk of dilution through capital increases to fund research and development. - FY2024RestatedAnnual report
「If we raise funds in the market, including through capital increases, in response to funding needs, the resulting increase in the total number of shares outstanding may dilute per-share value and reduce the value of our shares.」
The company reiterates the risk of dilution through capital increases to fund research and development. - FY2023First statedAnnual report
「If we raise funds in the market, including through capital increases, in response to funding needs, the resulting increase in the total number of shares outstanding may dilute per-share value and reduce the value of our shares.」
The company identifies the possibility that issuing new shares to fund research and development will dilute existing shareholders' equity value.